Clinical trial
Molecular Genetic and Pathological Studies of Anal Tumors
NCT00267787 · Stanford University, Other · Terminated
Key facts
| NCT number | NCT00267787 |
|---|---|
| Title | Molecular Genetic and Pathological Studies of Anal Tumors |
| Official title | Molecular Genetic and Pathological Studies of Anal Tumors |
| Lead sponsor | Stanford University, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Rectal Cancer, Colon Cancer, Colonic Neoplasms, Anal Cancer |
| Intervention type | Other |
| Interventions | genetic analysis |
| Enrollment | 7 |
| Start date | Sep 1, 2004 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2017 |
| First posted | Dec 21, 2005 |
| Last update posted | Dec 10, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: